Chaturvedi Vijaya, Sitailo Leonid A, Bodner Barbara, Denning Mitchell F, Nickoloff Brian J
Department of Pathology, Loyola University Chicago, IL 60153, USA.
Exp Dermatol. 2006 Jan;15(1):14-22. doi: 10.1111/j.0906-6705.2005.00383.x.
Whether terminal differentiation/stratum corneum formation of keratinocytes (KCs) represents a form of programmed cell death, utilizing mediators of classical apoptosis, is unclear. Apoptosis, an evolutionarily conserved death process, is comprised of extrinsic and intrinsic pathways, which converge using caspase 3. To define upstream and downstream caspases involved in terminal differentiation, we utilized human epidermal equivalents (EEs). Using submerged cultures comprised of human KCs, EEs were sequentially analyzed before and after being raised to an air/liquid (A/L) interface at 3-24 h intervals. At each time point, EEs were analyzed morphologically and for specific enzyme activity to distinguish different initiator (caspases 1, 2, 8, 9) and effector caspases (3, 6, 7). Terminal differentiation began at 6-8 h, as defined by stratum corneum with loricirin expression and completed at 18-24 h producing an epidermis resembling normal skin. Enzyme activity for caspases 1, 2, 3, 6, 7, 8, and 9 (but not 4, 5) was enhanced (>two-fold nmol/mg/h) at 3-6 h compared with submerged cultures. Processing of caspase 14 occurred at 18 h, and cleaved caspase 14 was increased at 24 h. Activated caspase 3-positive and terminal deoxynucleotidyl transferase-mediated nick end labeling-positive KCs were identified in EEs at 3-6 h corresponding to initiation sites of terminal differentiation. Addition of caspase inhibitors reduced levels of involucrin and loricrin in EEs raised to an A/L interface. We conclude caspases function as important death effectors strategically positioned at intersection of intrinsic and extrinsic pathways in KCs undergoing stratum corneum formation.
角质形成细胞(KCs)的终末分化/角质层形成是否利用经典凋亡介质代表一种程序性细胞死亡形式尚不清楚。凋亡是一种进化上保守的死亡过程,由外在和内在途径组成,这些途径通过半胱天冬酶3汇聚。为了确定参与终末分化的上游和下游半胱天冬酶,我们使用了人表皮替代物(EEs)。使用由人角质形成细胞组成的浸没培养物,在以3 - 24小时间隔升至气/液(A/L)界面之前和之后对EEs进行顺序分析。在每个时间点,对EEs进行形态学分析和特定酶活性分析,以区分不同的起始半胱天冬酶(半胱天冬酶1、2、8、9)和效应半胱天冬酶(3、6、7)。如由表达loricirin的角质层所定义,终末分化在6 - 8小时开始,并在18 - 24小时完成,产生类似于正常皮肤的表皮。与浸没培养物相比,在3 - 6小时时,半胱天冬酶1、2、3、6、7、8和9(但不是4、5)的酶活性增强(>两倍nmol/mg/h)。半胱天冬酶14的加工在18小时发生,并且在24小时时裂解的半胱天冬酶14增加。在3 - 6小时的EEs中鉴定出活化的半胱天冬酶3阳性和末端脱氧核苷酸转移酶介导的缺口末端标记阳性的角质形成细胞,对应于终末分化的起始位点。添加半胱天冬酶抑制剂可降低升至A/L界面的EEs中兜甲蛋白和loricirin的水平。我们得出结论,半胱天冬酶作为重要的死亡效应器,战略性地定位在经历角质层形成的角质形成细胞的内在和外在途径的交叉点。